Society of Toxicology (SOT 2019) 58th Annual Meeting & ToxExpo 2019

Event Date: March 10 - 14, 2019
Event Location: Booth 4081, Baltimore Convention Center, 1 West Pratt Street, Baltimore, MD 21201
Diapharma will attend the Society of Toxicology (SOT 2019) and exhibit at ToxExpo 2019 booth 4081. Please click here to schedule a meeting with us or email us directly.
View our SOT invitation postcard.
Our booth location
DILI and DIKI remain as frequent causes of drug termination in clinical trials or withdrawals from the market. Visit Diapharma at our booth to discuss promising biomarkers currently being evaluated. The M30 Apoptosense® ELISA detects hepatocyte apoptosis while M65®/M65 Epideath® ELISAs detect apoptosis and necrosis, whether caused by drugs, toxins, or disease. Diapharma offers an extensive line of liver and kidney injury biomarkers, including K18, HA, α-GST, and Collagen IV. Research use only.
About The Society of Toxicology (SOT) Annual Meeting
Over 80 scientific sessions, including six sessions designated as Innovations in Applied Toxicology (IAT) or Innovations in Toxicological Sciences (ITS)
Toxicology societies include:
- American College of Toxicology
- International Union of Toxicology
- IUTOX 15th International Congress of Toxicology
- Safety Pharmacology Society
- Society of Toxicologic Pathology
- Society of Toxicology
- Teratology Society
- The Toxicology Forum
Topics include:
- Publicly Available Exposure Tools to Inform the Toxic Substances Control Act
- Assay Development Principles and Good Research Practices for Rigor and Reproducibility in In Vitro Toxicology
- Complex Mixtures and UVCBs: Analysis, Testing, and Risk Assessment
- Developmental Toxicity of the Skeletal System: Interpretation of Findings in DART Studies and Implications for Risk Assessment
- Industrial Application of Computational Toxicology in the 21st Century
- Role of Toxicokinetics in Human Health Safety Assessments
- Mechanistic Understanding and Quantitative Risk Assessment in Immunotoxicology
- Applications and Review of Physiologically-Based Pharmacokinetic Modeling for Regulatory Risk Assessment
- Basic Course on Dermal and Ocular Toxicology
- Systematic Review in Toxicology
- Current Dose-Response Modeling Strategies and Applications in Chemical Risk Assessment
- Microbiome and Environmental Toxicants: From Study Design and Analysis to Regulatory Guidance
- Structural and Functional Alterations of Mitochondria in Chemically-Induced Cytotoxicity
- Robust Assembly of Human Tissues for Disease Modeling and Discovery
- Advances in In Vitro to In Vivo Extrapolation
- Alpha-Synuclein: A Good Protein Turned Bad in Chronic Brain Diseases with Toxicological Implications
- Potential Application of Next-Generation Toxicological Tools
- Novel Genetic-Based Tools for Evaluating Toxicity Potential, Mechanism of Action, and Population Dynamics
- Computational Modeling to Risk Assessment of Endocrine Disruptors
- MALDI Tissue Imaging: A New Tool for Making TK/TD Connections to Histopathology
- Mechanisms and Effects of Diabetogenic Environmental Metals: Type II Diabetes Mellitus and Diabetic Kidney Disease
- Pharmaceutical Investigative Toxicology: Case Studies in Optimizing Drug Discovery and Guiding Human Risk Assessment
- Cellular Model Systems to Assess Individual Risk to Neurotoxicants
- Electronic Waste: An Evolving Global Health Concern and Risk Assessment Challenge
- Federal Efforts in Rapidly Assessing Hazard and Risk to Emerging Threats and Emergency Response
- Immune-Epithelial Cell Cross Talk in Lung Toxicology and Disease
- Patterns of Co-Exposure and Its Implications for Understanding the Health Effects of Mixtures
- Cellular Dynamics and Models of Blood-Brain Barrier Developmental Toxicity ITS
- Strategic Development of Read-Across within the EU-ToxRisk Project and Beyond
- Rethinking Chemical Carcinogenicity Assessment
- Applying Systems Biology Approaches to Understand the Joint Action of Chemical and Nonchemical Stressors
- NextGen Renal Proximal Tubule Toxicity Screening: Novel Cellular Model and Complex Culture Platforms
- Classification of Substances as Endocrine Disruptors Has a Public Health Benefit
- Expanding the Definition and Understanding of Endothelial Dysfunction (ED) Due to Inhaled Toxicants
- Stem Cells and Metals Toxicity: From Tissue Regeneration and Repair to Carcinogenesis
- Systems Toxicology Approaches to the Science of Safety Evaluation
- Using Zebrafish as a Model to Understand and Ultimately Prevent Neurotoxicity
- Emergent Mechanisms of Cytochrome P450 Gene Regulation: Defining an Improved Roadmap towards 21st Century Pharmacogenomics
- Predicting Metabolic Clearance Rates for Drug Leads and Environmental Chemical Risk Assessment
- Shifting Currents in Predictive Toxicology and Safety Evaluation with In Vitro and Alternative Approaches
- Strategies to Mitigate the Health Impacts of Air Pollutants in Susceptible Populations
- Explicating the Pathogenic Environmental Factors in Nonalcoholic Fatty Liver Disease
- Integrated ‘Omics Approaches to Toxicity Assessments
- Scientific and Regulatory Update in the Application of the 3Rs Principle in Chemical and Drug Development
- Innovation in Biomarker Qualification
- Microbiota and Contributions to Neurodevelopment: Implications in Neurological Function, Behavior, and Toxicity
- Novel Safety Biomarker Qualification
- Perfluoroalkyl Substances (PFAS): Global and Persistent Environmental Contaminants
- Species Relevance: Approaches to Determine the Most Relevant Species for Safety Assessment of Pharmaceutical Products
- Humanized Mouse Models for Evaluations of Immune Function and Preclinical Immunotoxicology Studies
- Toxicity of Natural Products Alone and in Combination with Pharmaceutical Agents
- New Approaches Using Mode-of-Action to Predict Acute and Systemic Toxicity IAT
- Utility of Echocardiography in Cardiac Safety Assessment
- Effective Alternatives for Acute Oral and Inhalation Systemic Toxicity Testing
- Improving Carcinogenicity Assessments of Human Pharmaceuticals and Pesticides
- Dynamic RNA Modifications in Environmental Response and Disease
- Understanding and Managing Ocular Findings in General Toxicology Studies
- Nerve Agent Poisoning: Mechanisms of Toxicity, Recent Releases, Verification, and Innovative Treatment Approaches
- Reproductive and Developmental Toxicity Related to Electronic Cigarettes
- Immune System of Occupationally-Relevant Exposures to Multiwalled Carbon Nanotubes
- Chemically Synthesized Therapeutic Peptides
- Oxidative Stress in Health and Disease: Mechanisms, Methods of Detection, and Biomarkers
- In Vitro Developmental Toxicity Assays and Building Integrated Testing Strategies
- Air Pollution-Induced Cardiovascular Toxicity: Endothelial Progenitor Cells as Critical Mediators
- Microphysiological Systems: A New Era in Neurotoxicology?
- Risk Assessment of Consumer Products and Articles: Critical Considerations and Case Studies for Characterizing and Quantifying Consumer-Relevant Exposures to Chemicals and Nanomaterials
- Biomarkers Unique to Dependence Toxicity in Adolescents
- Nerve Agent and Pesticide Poisoning: Best Practice Methodologies for Assessing Long-Term Health Effects
- Causes and Outcomes of Epigenetic Dysregulation by Carcinogenic Metals
- Preconception Exposure to Toxicants: Assessing Gamete Quality and Reproductive Outcomes
- Use of Adverse Outcome Pathways to Design Nonanimal Testing Strategies for Assessing Inhalation Toxicity
About the Society of Toxicology (SOT)
Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology.
The society organizes an annual meeting (usually in the early spring) and several smaller colloquia via its special interest sections and groups. It publishes the journal Toxicological Sciences, the newsletter Communiqué, as well as public position papers and guidelines on conflicts of interest in toxicology.
About ToxExpo
ToxExpo is a gathering of over 300 toxicology-related companies and organizations with 6,000 attendees in the fields of regulatory & safety, general toxicology, risk assessment, and neurotoxicology. ToxExpo occurs over three days in-person and year-round online. ToxExpo is a venue which facilitates face-to-face interactions, networking and learning opportunities with a common goal of advancing scientific research.
Future meetings are planned in Hawaii 2019 (IUTOX ICTXV) and Anaheim 2020 (59th Annual Meeting).
SOT 2019 | Diapharma at SOT | SOT | ToxExpo 2019 | Twitter | Facebook | SOT Facebook Event | YouTube | Baltimore Convention Center